
Sky Labs CART: A Cuffless BP Ring With Real Regulatory Approval
BiohackingCuffless blood pressure monitoring has been the wearable industry’s most promised and least delivered capability. Sky Labs’ CART ring has now earned UK MHRA marketing authorization—following CE-MDR clearance in January 2026—backed by a clinical dataset of 320,535 arterial line blood pressure samples from 4,185 subjects. This is not a wellness app with a heart-rate proxy. It is a ring-form blood pressure monitor that has completed the same regulatory pathway as hospital equipment.
What Clinical Clearance Actually Required
The CART platform uses photoplethysmography (PPG) with multiple optical sensors and a deep learning algorithm trained specifically on A-line (arterial catheter) blood pressure data—the gold standard measurement method used in operating rooms. The accuracy target: mean error within ±5 mmHg, standard deviation within ±8 mmHg, which meets the European Society of Hypertension validation standard for ambulatory blood pressure monitors.
The clinical validation study, published in Scientific Reports (Joung et al., 2023, PMID 38196118), confirmed the accuracy against the A-line gold standard and found no performance differences based on skin color—a failure mode that has affected several competing photoplethysmographic devices. IP58 waterproofing allows continuous wear including in the shower.
In South Korea, where the CART BP pro received MFDS (Korean FDA-equivalent) approval in March 2023, the product is now prescribed in over 1,700 hospitals and clinics including tertiary hospitals, and exceeded 150,000 cumulative prescriptions within one year of launch. Korean insurance reimbursement has been recognized under the existing 24-hour ambulatory blood pressure monitoring procedure code. Otsuka Pharmaceutical signed an exclusive Japan commercialization deal in February 2026.
Why 24-Hour Cuffless Monitoring Matters
Standard blood pressure measurement is a point-in-time reading that misses nocturnal hypertension—elevated blood pressure during sleep that standard daytime readings don’t capture and that carries independent cardiovascular risk. Traditional 24-hour ambulatory blood pressure monitors (ABPMs) use an inflatable cuff that activates repeatedly through the night, disrupting sleep and limiting compliance. The CART ring captures continuous monitoring without position constraints (traditional ABPM requires the cuff to be at heart level; CART maintains accuracy across arm positions, per a separate 2026 clinical study).
For longevity-focused practitioners tracking cardiovascular biomarkers alongside lipid panels, HbA1c, and inflammatory markers, 24-hour blood pressure including nocturnal patterns adds a dimension that wrist-based optical monitors cannot currently provide at clinical accuracy. For context on how this fits into broader diagnostic stacks, see the continuous biosensing architecture analysis.
The UK consumer price has not yet been announced following the MHRA approval; the Korean consumer version launched at 550,000 KRW (approximately $392 USD) in September 2025. The product is sold directly through Sky Labs’ online store rather than general retail, and UK launch is expected through pharmacies and hospital channels. Sky Labs’ device page: skylabs.io/en/consumer/product-info.
The So What
The CART ring’s regulatory trajectory demonstrates what clinical-grade wearable blood pressure monitoring actually requires: a validated algorithm trained on arterial line data, peer-reviewed accuracy confirmation, and full medical device regulatory review—not a consumer wellness claim backed by internal testing. The market for consumer blood pressure monitors is substantial, but most products currently sold in this category lack any of the clinical validation that the CART ring has completed. For anyone building a serious cardiovascular monitoring protocol—particularly those with family history of hypertension or atherosclerotic disease, or those monitoring response to lifestyle interventions—the CART ring is the first ring-form device with the evidentiary foundation to make 24-hour blood pressure data clinically meaningful. Consult a qualified healthcare provider to determine appropriate monitoring protocols for your specific situation.
Photo by Andrey Matveev on Pexels
Source: Longevity.Technology
Content created with AI assistance and reviewed for accuracy.
Join the conversation
Stack Insiders is our free community for readers who want to go deeper — share resources, ask questions, and connect with others across every vertical we cover.
Join Stack Insiders →